Savara's experimental therapy, molgramostim, shows potential in treating a rare disease that causes breathing difficulties, offering hope for patients with autoimmune pulmonary alveolar proteinosis (aPAP).
The urgent need to address a dangerous strain of mpox in Africa, with fatality rates of approximately 5% in adults and 10% in children, is highlighted by the World Health Organization.
The World Health Organization has issued warnings about falsified semaglutides used in diabetes and weight-loss drugs, following the detection of altered batches of products in Brazil, the UK, and the U.S.
Nestle introduces Vital Pursuit, a new food brand tailored for people taking weight-loss drugs like Wegovy, focusing on high-protein, nutrient-dense meals while navigating regulatory concerns and competition in the growing market targeting GLP-1 medication users.
Cyberattack on Ascension hospitals across the U.S. compromises patient care, leading to medication errors, delayed lab results, and patient safety risks, as health workers struggle without access to critical electronic systems.
A call to action for the White House Initiative on Women's Health Research to prioritize critical research areas addressing the unique health needs of older women, who have been historically underrepresented in medical studies.